OMIM References: Difference between revisions

From Embryology
Line 269: Line 269:
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601321 NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601321 NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601450 DISLOCATION OF THE HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL] DYSMORPHISM
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601450 DISLOCATION OF THE HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL] DYSMORPHISM
=== Musculoskeletal ===

====Muscular Dystrophy====
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310200 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253800 FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; FCMD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253600 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT; EDMD2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310300 EMERY-DREIFUSS MUSCULAR DYSTROPHY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600119 SARCOGLYCAN, ALPHA; SGCA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=159000 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600334 TIBIAL MUSCULAR DYSTROPHY, TARDIVE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253601 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254110 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=159001 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310095 MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=257950 MUSCULAR DYSTROPHY, OCULOPHARYNGEAL, AUTOSOMAL RECESSIVE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B; FSHMD1B]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=156225 LAMININ, ALPHA-2; LAMA2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=160900 DYSTROPHIA MYOTONICA; DMPK]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600900 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=236670 WALKER-WARBURG SYNDROME]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254130 MIYOSHI MYOPATHY; MM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601253 CAVEOLIN 3; CAV3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=226670 EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158810 MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601287 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603511 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1D; LGMD1D]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254100 MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=159050 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254090 MUSCULAR DYSTROPHY, SCLEROATONIC]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253900 MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602771 MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE, WITH EARLY SPINE RIGIDITY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253590 MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600506 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 4; LGMD4]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=277320 VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601170 MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601173 MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253850 MUSCULAR DYSTROPHY, CONGENITAL, EICHSFELD TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603323 MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310000 MUSCULAR DYSTROPHY, MABRY TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601954 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254000 MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602067 CARDIOMYOPATHY, DILATED, 1F; CMD1F]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601846 MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309660 MENTAL RETARDATION, SCAPULOPERONEAL MUSCULAR DYSTROPHY, AND LETHAL CARDIOMYOPATHY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309950 MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158800 MUSCULAR DYSTROPHY, BARNES TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309930 MUSCULAR DYSTROPHY, CARDIAC TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601278 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY REGION GENE 1; FRG1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=204730 AMINOACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158600 MUSCULAR ATROPHY, JUVENILE SPINAL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253400 SPINAL MUSCULAR ATROPHY III; SMA3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603009 DYSFERLIN; DYSF]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=114240 CALPAIN, LARGE POLYPEPTIDE L3; CAPN3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253300 SPINAL MUSCULAR ATROPHY I; SMA1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601411 SARCOGLYCAN, DELTA; SGCD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=182970 SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE; FSHSMA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601282 PLECTIN 1; PLEC1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=150330 LAMIN A/C; LMNA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=128240 UTROPHIN; UTRN]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=307030 HYPERGLYCEROLEMIA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=181405 AMYOTROPHY, NEUROGENIC SCAPULOPERONEAL, NEW ENGLAND TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=128239 DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=193700 WHISTLING FACE-WINDMILL VANE HAND SYNDROME]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=271200 SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300600 ALBINISM, OCULAR, TYPE II; OA2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602668 DYSTROPHIA MYOTONICA 2; DM2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=234200 HALLERVORDEN-SPATZ DISEASE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=158580 MYOPATHY, DISTAL, WITH VOCAL CORD AND PHARYNGEAL WEAKNESS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602279 POLYADENYLATE-BINDING PROTEIN 2; PABP2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=123320 CREATINE PHOSPHOKINASE, ELEVATED SERUM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=181400 AMYOTROPHY, SCAPULOPERONEAL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=232300 GLYCOGEN STORAGE DISEASE II]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=160800 MYOTONIA CONGENITA, DOMINANT]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=253280 MUSCLE-EYE-BRAIN DISEASE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=313700 ANDROGEN RECEPTOR; AR]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601239 DYSTROBREVIN, ALPHA; DTNA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=306400 GRANULOMATOUS DISEASE, CHRONIC; CGD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=103220 ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120575 COMPLEMENT COMPONENT 1, q SUBCOMPONENT, GAMMA POLYPEPTIDE; C1QG]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120570 COMPLEMENT COMPONENT 1, q SUBCOMPONENT, BETA POLYPEPTIDE; C1QB]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=312600 RETINITIS PIGMENTOSA 2; RP2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120550 COMPLEMENT COMPONENT 1, q SUBCOMPONENT, ALPHA POLYPEPTIDE; C1QA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=131300 ENGELMANN DISEASE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600536 INTEGRIN, ALPHA-7; ITGA7]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=160500 MYOPATHY, DISTAL 1; MPD1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300030 DEAFNESS, X-LINKED 4, CONGENITAL SENSORINEURAL; DFN4]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=162200 NEUROFIBROMATOSIS, TYPE I; NF1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=163731 NITRIC OXIDE SYNTHASE 1; NOS1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 FILAMIN A, ALPHA; FLNA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=181430 SCAPULOPERONEAL MYOPATHY; SPM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601047 CAVEOLIN 1; CAV1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=114750 CARBONIC ANHYDRASE III; CA3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=312610 RETINITIS PIGMENTOSA 3; RP3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=136535 FORMIN; FMN]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309900 MUCOPOLYSACCHARIDOSIS TYPE II]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300023 RHO-GAP HEMATOPOIETIC PROTEIN C1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300170 CHROMOSOME X OPEN READING FRAME 5; CXORF5]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=134797 FIBRILLIN 1; FBN1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600109 PROXIMAL MYOTONIC MYOPATHY; PROMM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=314850 KELL BLOOD GROUP PRECURSOR; XK]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602415 DYSTROBREVIN, BETA; DTNB]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=248800 MARINESCO-SJOGREN SYNDROME; MSS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=151628 LINE RETROTRANSPOSABLE ELEMENT 2; LRE2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1; CSNB1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=305360 MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300087 X INACTIVATION, FAMILIAL SKEWED, 1; SXI1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=125660 DESMIN; DES]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=208100 ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=214150 CEREBROOCULOFACIOSKELETAL SYNDROME]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=302045 CARDIOMYOPATHY, DILATED, X-LINKED; XLCM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=160000 MYOGLOBIN; MB]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=232500 GLYCOGEN STORAGE DISEASE IV]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=179508 RAS-ASSOCIATED PROTEIN RAB1; RAB1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=190180 TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=306700 HEMOPHILIA A]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=160570 MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=257300 NONDISJUNCTION]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=188840 TITIN; TTN]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=276901 USHER SYNDROME, TYPE IIA; USH2A]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=255800 SCHWARTZ-JAMPEL SYNDROME; SJS]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=301500 ANGIOKERATOMA, DIFFUSE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=314700 XG BLOOD GROUP SYSTEM; XG; PBDX]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601484 SELENOPROTEIN P, PLASMA, 1; SEPP1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120220 COLLAGEN, TYPE VI, ALPHA-1; COL6A1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600341 TYRO3 PROTEIN TYROSINE KINASE; TYRO3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; XMEA; MEAX]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600538 PEROXIDE REDUCTASE, THIOREDOXIN-DEPENDENT; TDPX1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600118 WARBURG MICRO SYNDROME]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601048 CAVEOLIN 2; CAV2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=106210 PAIRED BOX HOMEOTIC GENE 6; PAX6]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=117000 CENTRAL CORE DISEASE OF MUSCLE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=123270 CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=306190 GONADOTROPIN DEFICIENCY; GTD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=305400 FACIOGENITAL DYSPLASIA; FGD1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=302960 CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300500 ALBINISM, OCULAR, TYPE 1; OA1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300048 INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300037 GLYPICAN 3; GPC3]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300100 ADRENOLEUKODYSTROPHY; ALD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300036 SOLUTE CARRIER FAMILY 6, MEMBER 8; SLC6A8]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=312820 SARCOMA, SYNOVIAL, X BREAKPOINT 1; SSX1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300081 DEOXYRIBONUCLEASE I-LIKE 1; DNASE1L1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120240 COLLAGEN, TYPE VI, ALPHA-2; COL6A2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=308100 ICHTHYOSIS, X-LINKED]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=308840 L1 CELL ADHESION MOLECULE; L1CAM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=314300 TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=277720 WHISTLING FACE SYNDROME, RECESSIVE FORM]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309530 MENTAL RETARDATION, X-LINKED NONSPECIFIC, TYPE 1; MRX1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=275630 TRIGLYCERIDE STORAGE DISEASE WITH IMPAIRED LONG-CHAIN FATTY ACID OXIDATION]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309000 LOWE OCULOCEREBRORENAL SYNDROME; OCRL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600308 AQUAPORIN 4; AQP4]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601143 DYNACTIN 1; DCTN1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601160 LISSENCEPHALY SYNDROME TYPE III]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601162 SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=114250 CALSEQUESTRIN, FAST-TWITCH, SKELETAL MUSCLE 1; CASQ1; CASQ]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=256030 NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=255600 MYOSCLEROSIS, CONGENITAL, OF LOWENTHAL]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=109150 MACHADO-JOSEPH DISEASE; MJD]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=140300 HASHIMOTO STRUMA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=151626 LINE RETROTRANSPOSABLE ELEMENT 1; LRE1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600310 CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601296 MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=232400 GLYCOGEN STORAGE DISEASE III]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601556 ATAXIN 1; ATX1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=224050 DYSEQUILIBRIUM SYNDROME; DES]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=220290 DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 1; DFNB1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=212905 CEREBELLAR ATAXIA WITH NEURONAL MIGRATION DEFECT]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602137 NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 2; NDUFA2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=180200 RETINOBLASTOMA; RB1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=178300 PTOSIS, HEREDITARY CONGENITAL 1; PTOS1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=169400 PELGER-HUET ANOMALY]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164400 SPINOCEREBELLAR ATAXIA 1; SCA1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=161800 NEMALINE MYOPATHY 1, AUTOSOMAL DOMINANT; NEM1]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603073 ZIC FAMILY MEMBER 2; ZIC2]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=100800 ACHONDROPLASIA; ACH]
* [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=258450 OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL]


== 1999 OMIM Pages ==
== 1999 OMIM Pages ==

Revision as of 11:13, 23 March 2010

Introduction

There are many different Online Mendelian Inheritence in Man (OMIM) reference materials used in UNSW Embryology. Selected OMIM references can also be found on the Abnormalities (page 2) of each section of Notes and there are also search buttons that will perform searches using specific term(s) of external databases. Some search results will allow access to the full original document, while others may require a Journal subscription to access the full document.

Students when referencing specific materials should as much as possible cite the original Research article and not Review articles. When wanting to give a broad overview or summaries of the field, the Review articles should be cited (and indicated as "reviews"). Students should also avoid direct text cut and paste and if absolutely necessary should place in "quotation marks" citing the original reference.


About OMIM "Online Mendelian Inheritance in Man OMIM is a comprehensive, authoritative, and timely compendium of human genes and genetic phenotypes. The full-text, referenced overviews in OMIM contain information on all known mendelian disorders and over 12,000 genes. OMIM focuses on the relationship between phenotype and genotype. It is updated daily, and the entries contain copious links to other genetics resources." OMIM



Links: OMIM | Citing OMIM?

2010 OMIM Pages by Developmental Topic

Week 1

Fertilization

Spermatozoa Motility

Spermatozoa

Cardiovascular

Tetralogy of Fallot

Atrial Septal Defect

Musculoskeletal


====Muscular Dystrophy====


1999 OMIM Pages

In 1999 I searched the Online Mendelian Inheritence in Man (OMIM) database and selected a small number of references for each topic. These earlier searches are now slightly out of date, but should still be a good starting point for those interested in the topics.

These pages retain the original earlier site (Version 3) page layout.

Week 1

Fertilization

Week 2

Week 3

Abnormal Development

Neural

Cardiovascular

Musculoskeletal

Gastrointestinal

Head and Neck

Coelomic Cavity

Respiratory

Neural Crest

Senses

Urogenital

Kidney

Gonad

Endocrine